1. Home
  2. EEA vs RPID Comparison

EEA vs RPID Comparison

Compare EEA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The European Equity Fund Inc.

EEA

The European Equity Fund Inc.

HOLD

Current Price

$10.58

Market Cap

73.5M

Sector

Finance

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.11

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEA
RPID
Founded
1986
2006
Country
Germany
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
84.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EEA
RPID
Price
$10.58
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
14.3K
275.8K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
1.92%
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$9.62
$1.09
52 Week High
$11.43
$4.94

Technical Indicators

Market Signals
Indicator
EEA
RPID
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
EEA
RPID

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: